LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2025 MaTOS Breast 2025 MaTOS GU 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Clear Displaying 1,576 - 1,600 of 2,995 « 1 … 62 63 64 65 66 … 120 » Immunotherapy Updates in Lung Cancer 2024 By: Christine M. Lovly, MD, PhD View PDF Metastatic Lung Immunotherapy Updates By: Chul Kim, MD, MPH View PDF Bi-Specific Inhibitor & ADC in Lung Cancer By: Chul Kim, MD, MPH View PDF Bi-Specific Inhibitor & ADC in Lung Cancer By: Chul Kim, MD, MPH View Video Screening in Lung Cancer: Challenges and Obstacles By: Claudia Henschke, MD, PhD View PDF Screening in Lung Cancer: Challenges and Obstacles By: Claudia Henschke, MD, PhD View Video Lung Cancer Screening Programs: How do We ‘Take it to the Next Level’ to Improve Lung Cancer Outcomes? By: Claudia I. Henschke, MD, PhD View PDF Other Oncogene-Driven Cancers By: Collin Blakely, MD, PhD View PDF Other Oncogene-Driven Cancers By: Collin Blakely, MD, PhD View PDF Other Oncogene-Driven Cancers By: Collin Blakely, MD, PhD View Video EGFR-Mutated Lung Cancers By: Collin Blakely, MD, PhD View PDF EGFR-Mutated Lung Cancers By: Collin Blakely, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage By: Collin Blakely, MD, PhD View PDF EGFR Mutated Lung Cancer - Advanced Stage By: Collin Blakely, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage By: Collin Blakely, MD, PhD View PDF EGFR Mutated Lung Cancer - Advanced Stage By: Collin Blakely, MD, PhD View Video ALK, ROS1 & NTRK Mutations in NSCLC By: Corey Langer, MD View PDF ALK, ROS1 & NTRK Mutations in NSCLC By: Corey Langer, MD View Video Stage III Non-Surgical Candidate NSCLC – Controversies in this Arena (Tumors with Actionable Genes and No PD-L1 Expression) By: Corey Langer, MD View PDF Building the Case for HER-2 Inhibitors in NSCLC By: Corey Langer, MD View PDF Building the Case for HER-2 Inhibitors in NSCLC By: Corey Langer, MD View Video Stage III Non-Surgical Candidate NSCLC – Controversies in this Arena (Tumors with Actionable Genes and No PD-L1 Expression) By: Corey Langer, MD View Video Targeted Therapies in Lung Cancer By: D. Ross Camidge, MD, PhD View PDF Targeted Therapies in Lung Cancer By: D. Ross Camidge, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage By: David Gandara, MD View PDF
